Urinary Polyaromatic Hydrocarbons Are Associated with Adult Emphysema, Chronic Bronchitis, Asthma, and Infections: US NHANES, 2011-2012
Overview
Toxicology
Authors
Affiliations
Links between environmental chemicals and human health have emerged over the last few decades, but the effects from polyaromatic hydrocarbons were less studied, compared to other commonly known environmental chemicals such as heavy metals, phthalates, arsenic, phenols, pesticides, etc. Therefore, the aim of the study was to examine the relationships of urinary polyaromatic hydrocarbons and adult respiratory health conditions using a large human sample in a national and population-based setting in recent years. Data were retrieved from United States National Health and Nutrition Examination Surveys, 2011-2012 including demographics, self-reported health conditions, and urinary polyaromatic hydrocarbons. Statistical analyses including chi-square test, t test, and survey-weighted logistic regression modeling were performed. Of 5560 American adults aged 20-80, urinary 2-hydroxyfluorene and 3-hydroxyfluorene were positively associated with emphysema (OR, 1.60, 95 % CI 1.26 to 2.03, P = 0.001 and OR, 1.42, 95 % CI 1.15 to 1.77, P = 0.003, respectively) and chronic bronchitis (OR, 1.42, 95 % CI 1.04 to 1.94, P = 0.031 and OR, 1.40, 95 % CI 1.03 to 1.91, P = 0.036, respectively), while 2-hydroxynaphthalene (2-naphthol) was likely to be borderline associated with emphysema and chronic bronchitis. Conversely, urinary 1-hydroxyphenanthrene, 3-hydroxyphenanthrene, 1-hydroxypyrene, and 4-hydroxyphenanthrene were inversely associated with asthma and infections. Urinary polyaromatic hydrocarbons are associated with adult respiratory health conditions, although the causality cannot be established. For future research, studies using large human sample across regions to longitudinally monitor would be suggested. For practice and policy-making, regulation on minimizing polyaromatic hydrocarbons exposure to protect respiratory health might need to be considered in future health and environmental policies and intervention programs.
Microplastic and plastic pollution: impact on respiratory disease and health.
Vasse G, Melgert B Eur Respir Rev. 2024; 33(172).
PMID: 39009408 PMC: 11262622. DOI: 10.1183/16000617.0226-2023.
Xiao Y, Zhang L, Liu H, Huang W Front Public Health. 2023; 11:1248812.
PMID: 38074734 PMC: 10703366. DOI: 10.3389/fpubh.2023.1248812.
Environmental Substances Associated with Chronic Obstructive Pulmonary Disease-A Scoping Review.
Elonheimo H, Mattila T, Andersen H, Bocca B, Ruggieri F, Haverinen E Int J Environ Res Public Health. 2022; 19(7).
PMID: 35409627 PMC: 8997594. DOI: 10.3390/ijerph19073945.
Rahman H, Niemann D, Munson-McGee S Lung. 2022; 200(2):237-249.
PMID: 35178625 DOI: 10.1007/s00408-022-00518-1.
Systematic Review of Exposure to Polycyclic Aromatic Hydrocarbons and Obstructive Lung Disease.
Nwaozuzu C, Partick-Iwuanyanwu K, Abah S J Health Pollut. 2021; 11(31):210903.
PMID: 34434595 PMC: 8383797. DOI: 10.5696/2156-9614-11.31.210903.